Logo image of BKYI

BIO-KEY INTERNATIONAL INC (BKYI) Stock Fundamental Analysis

USA - NASDAQ:BKYI - US09060C5076 - Common Stock

0.7574 USD
-0.02 (-2.27%)
Last: 10/7/2025, 8:11:41 PM
Fundamental Rating

2

Taking everything into account, BKYI scores 2 out of 10 in our fundamental rating. BKYI was compared to 281 industry peers in the Software industry. BKYI has a bad profitability rating. Also its financial health evaluation is rather negative. BKYI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BKYI has reported negative net income.
BKYI had a negative operating cash flow in the past year.
BKYI had negative earnings in each of the past 5 years.
BKYI had a negative operating cash flow in each of the past 5 years.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

BKYI has a worse Return On Assets (-38.30%) than 80.43% of its industry peers.
BKYI's Return On Equity of -58.78% is on the low side compared to the rest of the industry. BKYI is outperformed by 72.24% of its industry peers.
Industry RankSector Rank
ROA -38.3%
ROE -58.78%
ROIC N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

BKYI has a better Gross Margin (78.71%) than 76.87% of its industry peers.
In the last couple of years the Gross Margin of BKYI has grown nicely.
BKYI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BKYI has more shares outstanding
Compared to 5 years ago, BKYI has more shares outstanding
The debt/assets ratio for BKYI is higher compared to a year ago.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -17.00, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
BKYI has a worse Altman-Z score (-17.00) than 92.17% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that BKYI is not too dependend on debt financing.
BKYI has a Debt to Equity ratio of 0.07. This is comparable to the rest of the industry: BKYI outperforms 57.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -17
ROIC/WACCN/A
WACC12.63%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

BKYI has a Current Ratio of 1.14. This is a normal value and indicates that BKYI is financially healthy and should not expect problems in meeting its short term obligations.
BKYI has a worse Current ratio (1.14) than 65.84% of its industry peers.
BKYI has a Quick Ratio of 1.05. This is a normal value and indicates that BKYI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.05, BKYI is not doing good in the industry: 67.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.05
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

BKYI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 89.08%, which is quite impressive.
The Revenue has grown by 13.96% in the past year. This is quite good.
The Revenue has been growing by 25.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)89.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%48.69%

3.2 Future

The Earnings Per Share is expected to grow by 35.20% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 7.75% on average over the next years.
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -20 -40 -60 -80 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKYI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as BKYI's earnings are expected to grow with 35.20% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.2%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BKYI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (10/7/2025, 8:11:41 PM)

0.7574

-0.02 (-2.27%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-12 2025-11-12
Inst Owners1.75%
Inst Owner Change0%
Ins Owners5.98%
Ins Owner Change6.34%
Market Cap5.20M
Analysts82.86
Price Target2.04 (169.34%)
Short Float %0.6%
Short Ratio0.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)9.09%
EPS NY rev (3m)19.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 0.76
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS1.01
BVpS1
TBVpS0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.3%
ROE -58.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.71%
FCFM N/A
ROA(3y)-114.53%
ROA(5y)-83.12%
ROE(3y)-379.98%
ROE(5y)-244.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.53%
GM growth 5YN/A
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.92%
Cap/Sales 0.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.05
Altman-Z -17
F-Score5
WACC12.63%
ROIC/WACCN/A
Cap/Depr(3y)8.01%
Cap/Depr(5y)11.47%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y73.12%
EPS Next 2Y35.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y10.69%
Revenue growth 5Y25.01%
Sales Q2Q%48.69%
Revenue Next Year-5.83%
Revenue Next 2Y7.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y62.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.9%
OCF growth 3YN/A
OCF growth 5YN/A